BioPharma Dive ١٨ مايو ٢٠٢٦ Unlocking more value from mature drug products through strategic outsourcing
BioPharma Dive ١٢ مايو ٢٠٢٦ Bristol Myers, Hengrui join forces in drugmaking alliance worth up to $15.2 billion
BioPharma Dive ١٢ مايو ٢٠٢٦ A year after Vertex’s big launch, pain drug research faces a pivotal moment